The impact of home treatment and self-administration of omalizumab on chronic urticaria

The impact of home treatment and self-administration of omalizumab on chronic urticaria

Background: Patients suffering from Chronic Spontaneous Urticaria (CSU) may be recalcitrant to treatment with high dose second-generation antihistamines. These patients are, according to international guidelines, eligible to treatment with omalizumab. Treatment with omalizumab has proven to be very...

Full description

Bibliographic Details
Main Authors: Anne Christine Wiuff, MBBS, Malthe Alexander Knudsgaard Wiis, MBBS, Sofine Heilskov, MD, Anne Sofie Frølunde, MD, Jennifer Astrup Sørensen, MD, Mette Deleuran, MD, DMSc, Simon Francis Thomsen, MD, PhD, DMSc, Christian Vestergaard, MD, PhD, DMSc
Format: Article
Language:English
Published: Elsevier 2022-12-01
Series:World Allergy Organization Journal
Subjects:
Chronic spontaneous urticaria
Omalizumab
Self-administration
Home-treatment
Patient satisfaction
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455122001016

Internet

http://www.sciencedirect.com/science/article/pii/S1939455122001016

Similar Items